TickerFacts.

Achieve Life Sciences, Inc. (ACHV): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$49.47M
Year ended 2025-12-31
$34.86M2009-12-31: $34.86M2010-12-31: -$26.91M2011-12-31: -$20.34M2012-12-31: -$43.78M2013-12-31: -$36.18M2014-12-31: -$17.39M2015-12-31: -$721.0K2016-12-31: -$248.0K2018-12-31: -$10.67M2019-12-31: -$15.27M2020-12-31: -$13.49M2023-12-31: -$24.50M2025-12-31: -$49.47M-$49.47M
2009-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$49.47Mn/a2026-03-24, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31-$24.50Mn/a2026-03-24, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31-$13.49Mn/m2023-03-16, From 2020-01-01
2019-12-31-$15.27Mn/m2022-03-10, From 2019-01-01
2018-12-31-$10.67Mn/a2021-03-11, From 2018-01-01
No annual figure between 2016-12-31 and 2018-12-31.
2016-12-31-$248.0Kn/m2019-03-14, From 2016-01-01
2015-12-31-$721.0Kn/m2018-03-01, From 2015-01-01
2014-12-31-$17.39Mn/m2017-02-23, From 2014-01-01
2013-12-31-$36.18Mn/m2016-03-09, From 2013-01-01
2012-12-31-$43.78Mn/m2015-03-26, From 2012-01-01
2011-12-31-$20.34Mn/m2014-03-11, From 2011-01-01
2010-12-31-$26.91Mn/m2013-03-07, From 2010-01-01
2009-12-31$34.86Mn/a2012-03-08, From 2009-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Achieve Life Sciences, Inc. (ACHV)2025-12-31-$49.47Mn/a
Q/C Technologies, Inc. (QCLS)2025-12-31-$10.82Mn/a
Immucell Corp (ICCC)2025-12-31$1.22Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$25.37Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$9.79Mn/m
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31-$5.91Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$19.77Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.04Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$213.66Mn/m

Compare ACHV, QCLS, ICCC, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗